The Drugs Controller General of India (DCGI) has permitted #ZydusCadila to conduct Phase III trials of #ZyCoVD, the two-dose regimen of its needle-free #Covid vaccine. pic.twitter.com/yPmQrmuNrG— IANS Tweets (@ians_india) October 5, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


